Blood formula may predict who survives major surgery bleeding
NCT ID NCT06021184
First seen May 15, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This study looks at how the amount of fibrinogen (a protein that helps blood clot) in blood transfusions affects survival and daily living abilities after major bleeding during surgery. Researchers will track about 1,700 adults who need multiple blood products during surgery. The goal is to find the best balance of fibrinogen to red blood cells to improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASSIVE TRANSFUSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ankara Bilkent city hospital
Ankara, Çankaya, 06800, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.